BioPharm News

Jan 11, 2018
By BioPharm International Editors
Sartorius Stedim Biotech will equip Abzena’s contract development and manufacturing facilities in Bristol, PA, and San Diego, CA, with single-use equipment and scale-up technologies.
Jan 11, 2018
By BioPharm International Editors
The 2018 Short Course program at Pittcon, taking place Feb. 24–Mar. 1, will feature 23 new short courses geared towards laboratory professionals.
Jan 10, 2018
By BioPharm International Editors
Pharma Team Up has launched Poseidon, an integrated ocean freight program, to address the disconnect between pharma companies and their logistics providers.
Jan 10, 2018
Will Alex Azar’s experience in the pharmaceutical industry help or hurt the initiative to keep medications affordable?
Jan 09, 2018
By BioPharm International Editors
The company announced 15 new collaborations focused on addressing unmet medical needs, including using artificial intelligence in the early detection of Alzheimer’s disease, saliva testing for throat cancers, and using the microbiome to treat sleep disorders.
Jan 08, 2018
By BioPharm International Editors
AptarGroup’s Landfill Free Certification program addresses the issue of waste production from pharmaceutical manufacturing processes by prompting its facilities to reduce and reuse operation waste.
Jan 05, 2018
By BioPharm International Editors
FDA noted in a recent inspection that American CryoStem was receiving and processing adipose tissue into a product called Atcell, and then marketing the product without agency approval.
Jan 05, 2018
By BioPharm International Editors
FDA Commissioner Gottlieb expects that the saline and amino acid drug shortages from Puerto Rican manufacturing facilities will improve in the early part of 2018.
Jan 05, 2018
By BioPharm International Editors
The companies aim to develop a potential zinc finger protein transcription factor-based gene therapy for treating Lou Gehrig’s disease.
Jan 05, 2018
By BioPharm International Editors
The companies aim to discover and develop locked nucleic acid oligonucleotides as orally available therapies for treating inflammatory bowel diseases.
native1_300x100
lorem ipsum